Invokana Lawsuit Center
The nationwide law firm of Bernstein Liebhard LLP is now investigating potential Invokana lawsuits on behalf of individuals who were hospitalized due to ketoacidosis (diabetic ketoacidosis (DKA), ketosis or acidosis) while using this or any other Type 2 diabetes medication known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. Since May 2013, numerous patients who were prescribed these medications have reportedly sought emergency medical treatment or been hospitalized with this dangerous condition. The U.S. Food & Drug Administration (FDA) is now reviewing the safety of all SGLT2 inhbitors to determine if the risk of ketoacidosis should be noted on the drugs’ labels.
If you were hospitalized with ketoacidosis while taking Invokana or a similar diabetes medication, we urge you to contact our legal staff today to obtain a free case review. By filing an Invokana lawsuit, you may be able to obtain compensation for medical bills, lost wages, pain and suffering, and other damages related to your injuries.
SGLT2 Inhibitors and Ketoacidosis
Invokana (canagliflozin) and other SGLT2 inhibitors lower blood sugar in people with Type 2 diabetes by working with the kidneys to eliminate glucose through urination. In addition to Invokana, other drugs in this class include:
- Invokamet (canagliflozin and metformin)
- Farxiga (dapagliflozin)
- Xigduo XR (dapagliflozin and metformin extended-release)
- Jardiance (empagliflozin)
- Glyxambi (empagliflozin and linagliptin)
In May 2015, the FDA announced that it was reviewing the safety of all SGLT2 inhibitors after it had received 20 reports of acidosis (reported as diabetic ketoacidosis (DKA), ketosis, or ketoacidosis) among patients taking the drugs between May 2013 and June 6 2014. In all cases, patients required emergency room treatment or hospitalization.
- Breathing difficulty
- Nausea and vomiting
- Abdominal pain
- Changes in urination
- Lethargy, unusual fatigue or sleepiness
If not treated quickly, ketoacidosis can result in a diabetic coma, or even death.
According to the FDA, the cases of ketoacidosis associated with Invokana and other SGLT2 inhibitors were unusual, as this condition is usually associated with Type 1 diabetes. Patients generally present with high blood sugar levels, but in the cases reported to the FDA, blood sugar was only slightly elevated. Major illness, reduced food and fluid intake, and reduced insulin dose were noted in some reports as factors that could have influenced the ketoacidosis. The median time to onset of symptoms following initiation of drug therapy was 2 weeks.
Discuss Filing an Invokana Lawsuit with an Attorney Today
If you were diagnosed and hospitalized with ketoacidosis after using Invokana or another SGLT2 inhibitor, the attorneys at Bernstein Liebhard LLP are here to help. To learn more about the process for filing an Invokana lawsuit, please call 212-779-1414 to arrange for your free, no-obligation case review.
Proton Pump Inhibitors Linked To Chronic Kidney Disease
Studies have linked long-term use of popular heartburn drugs like Nexium, Prilosec and Prevacid to a range of serious side effects, including kidney failure and chronic kidney disease. The nationwide law of Firm of Bernstein Liebhard LLP is now accepting inquiries from individuals who suspect that a proton pump inhibitor caused their kidney problems. A number of nexium lawsuits have already been filed in U.S. courts that allege the drugs’ manufacturers withheld vital safety information from patients and doctors. If you are interested in learning more about this growing litigation, please visit the Nexium Lawsuit Center to contact our legal team. Our Firm is providing free, no-obligation legal reviews to anyone who may have experienced kidney damage as a result of Nexium, Prilosec or Prevacid, and they are available now to discuss your potential claim.